Prix
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de Centogene ?
Quel est le bénéfice par action (BPA) de Centogene ?
Quelles sont les évaluations des analystes et le prix cible de l'action Centogene ?
Quel est le chiffre d'affaires de Centogene sur les douze derniers mois ?
Quel est l'EBITDA de Centogene ?
Quel est le flux de trésorerie disponible de Centogene ?
Combien d'employés compte Centogene, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Centogene ?
Finances
- Capitalisation boursière
- 3,88 M $US
- BPA (TTM)
- -1,409 $US
- Free Float
- 11,76 M
- Recettes (TTM)
- 53,96 M $US
- EBITDA (TTM)
- -37,20 M $US
- Cash-flow disponible (TTM)
- -42,02 M $US
Cotation
- 52W span
- 0,0376 $US1,25 $US
Notes des analystes
L'objectif de prix est de 1,542 $US et l'action est analysée par 1 analystes.
Acheter
1
Hold
0
Vendre
0
Informations
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
- Salariés
- 493
- Industries
- Miscellaneous Commercial Services
- Secteur
- Soins de santé
Identifiant
- ISIN
- NL0014040206
- Ticker primaire
- CNTG